Artículos

Risperidone: An open-label, observational study of the efficacy, tolerability, and prescribing behavior in acutely exacerbated patients with schizophrenia / Frank Gerald Pajonk en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 293-300 Título : Risperidone: An open-label, observational study of the efficacy, tolerability, and prescribing behavior in acutely exacerbated patients with schizophrenia Tipo de documento: texto impreso Autores: Frank Gerald Pajonk, Autor ; Andreas Schreiner, Autor ; Stefan Peters, Autor Fecha de publicación: 2023 Artículo en la página: pp. 293-300 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Hostilidad, Observación, Patrones de práctica, Risperidona, Esquizofrenia. Resumen: Efficacy of atypical antipsychotic in acute schizophrenic episodes is still in debate. This study evaluated treatment practices over 7 years of initial treatment with oral risperidone in acutely exacerbated patients with schizophrenia and in a subgroup of highly agitated, tense, and aggressive patients. Additionally, the study investigated the efficacy and tolerability of risperidone in routine clinical practice. Link: ./index.php?lvl=notice_display&id=30893 [artículo] Risperidone: An open-label, observational study of the efficacy, tolerability, and prescribing behavior in acutely exacerbated patients with schizophrenia [texto impreso] / Frank Gerald Pajonk, Autor ; Andreas Schreiner, Autor ; Stefan Peters, Autor . - 2023 . - pp. 293-300. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 293-300 Palabras clave: Antipsicóticos, Hostilidad, Observación, Patrones de práctica, Risperidona, Esquizofrenia. Resumen: Efficacy of atypical antipsychotic in acute schizophrenic episodes is still in debate. This study evaluated treatment practices over 7 years of initial treatment with oral risperidone in acutely exacerbated patients with schizophrenia and in a subgroup of highly agitated, tense, and aggressive patients. Additionally, the study investigated the efficacy and tolerability of risperidone in routine clinical practice. Link: ./index.php?lvl=notice_display&id=30893

Ziprasidone in acute bipolar mania / Steven G. Potkin en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 301-310 Título : Ziprasidone in acute bipolar mania : A 21-day randomized, double blind, placebo controlled replication trial Tipo de documento: texto impreso Autores: Steven G. Potkin, Autor ; Paul E. Keck, Autor ; Scott Segal, Autor Fecha de publicación: 2023 Artículo en la página: pp. 301-310 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Enfermedad aguda, Antipsicóticos, Trastorno bipolar, Hospitalización, Piperazinas, Tiazoles. Resumen: In an earlier 21-day, placebo-controlled trial, ziprasidone was efficacious in improving symptoms of mania and was well tolerated. To confirm these results, a similarly designed 21-day trial was conducted. Link: ./index.php?lvl=notice_display&id=30894 [artículo] Ziprasidone in acute bipolar mania : A 21-day randomized, double blind, placebo controlled replication trial [texto impreso] / Steven G. Potkin, Autor ; Paul E. Keck, Autor ; Scott Segal, Autor . - 2023 . - pp. 301-310. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 301-310 Palabras clave: Enfermedad aguda, Antipsicóticos, Trastorno bipolar, Hospitalización, Piperazinas, Tiazoles. Resumen: In an earlier 21-day, placebo-controlled trial, ziprasidone was efficacious in improving symptoms of mania and was well tolerated. To confirm these results, a similarly designed 21-day trial was conducted. Link: ./index.php?lvl=notice_display&id=30894

Effects of rivastigmine on sustained attention in schizophrenia / Ingrid Aasen en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 311-317 Título : Effects of rivastigmine on sustained attention in schizophrenia : An fmri study Tipo de documento: texto impreso Autores: Ingrid Aasen, Autor ; Veena Kumari, Autor ; Tonmoy Sharma, Autor Fecha de publicación: 2023 Artículo en la página: pp. 311-317 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Corteza cerebral - efectos del medicamento, Inhibidores de colinesterasa, Terapia medicamentosa, Imagen de resonancia magnética, Fenilcarbamatos, Esquizofrenia - farmacoterapia. Resumen: This study assessed the neural correlates of the effects of rivastigmine, a CNS-selective cholinesterase inhibitor, given as an add-on therapy to antipsychotics-treated patients with schizophrenia who displayed moderate cognitive impairments, using functional magnetic resonance imaging (fMRI) during a sustained attention task. Link: ./index.php?lvl=notice_display&id=30895 [artículo] Effects of rivastigmine on sustained attention in schizophrenia : An fmri study [texto impreso] / Ingrid Aasen, Autor ; Veena Kumari, Autor ; Tonmoy Sharma, Autor . - 2023 . - pp. 311-317. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 311-317 Palabras clave: Antipsicóticos, Corteza cerebral - efectos del medicamento, Inhibidores de colinesterasa, Terapia medicamentosa, Imagen de resonancia magnética, Fenilcarbamatos, Esquizofrenia - farmacoterapia. Resumen: This study assessed the neural correlates of the effects of rivastigmine, a CNS-selective cholinesterase inhibitor, given as an add-on therapy to antipsychotics-treated patients with schizophrenia who displayed moderate cognitive impairments, using functional magnetic resonance imaging (fMRI) during a sustained attention task. Link: ./index.php?lvl=notice_display&id=30895

Sex differences in antidepressant response in recent antidepressant clinical trials / Arif Khan en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 318-324 Título : Sex differences in antidepressant response in recent antidepressant clinical trials Tipo de documento: texto impreso Autores: Arif Khan, Autor ; Amy E. Brodhead, Autor ; Kelly A. Schwartz, Autor Fecha de publicación: 2023 Artículo en la página: pp. 318-324 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno depresivo, Noradrenalina, Inhibidores selectivos de la recaptación de serotonina Resumen: Some previous reports suggest that women respond differently than men to antidepressant treatment. Much of this literature compares men and women's response to tricyclics to that of newer antidepressants (SSRIs, SNRI), or only examines one particular antidepressant. This study compares men and women's responses to 6 newer antidepressants. Link: ./index.php?lvl=notice_display&id=30896 [artículo] Sex differences in antidepressant response in recent antidepressant clinical trials [texto impreso] / Arif Khan, Autor ; Amy E. Brodhead, Autor ; Kelly A. Schwartz, Autor . - 2023 . - pp. 318-324. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 318-324 Palabras clave: Antidepresivos, Trastorno depresivo, Noradrenalina, Inhibidores selectivos de la recaptación de serotonina Resumen: Some previous reports suggest that women respond differently than men to antidepressant treatment. Much of this literature compares men and women's response to tricyclics to that of newer antidepressants (SSRIs, SNRI), or only examines one particular antidepressant. This study compares men and women's responses to 6 newer antidepressants. Link: ./index.php?lvl=notice_display&id=30896

Rapid antidepressant response after nocturnal trh administration in patients with bipolar type i and bipolar type ii major depression / Martin P. Szuba en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 325-330 Título : Rapid antidepressant response after nocturnal trh administration in patients with bipolar type i and bipolar type ii major depression Tipo de documento: texto impreso Autores: Martin P. Szuba, Autor ; Jay D. Amsterdam, Autor ; Antonio T. Fernando, Autor Fecha de publicación: 2023 Artículo en la página: pp. 325-330 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno bipolar, Cronoterapia, Infusiones Intravenosas, Pruebas Psicológicas, Hormonas tiroideas, Hormona liberadora de tirotropina. Resumen: Thyrotropin-releasing hormone (TRH) is a tripeptide that produces endocrine and behavioral effects in animals and humans. Some studies have shown transient antidepressant activity after morning administration of TRH. Link: ./index.php?lvl=notice_display&id=30897 [artículo] Rapid antidepressant response after nocturnal trh administration in patients with bipolar type i and bipolar type ii major depression [texto impreso] / Martin P. Szuba, Autor ; Jay D. Amsterdam, Autor ; Antonio T. Fernando, Autor . - 2023 . - pp. 325-330. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 325-330 Palabras clave: Trastorno bipolar, Cronoterapia, Infusiones Intravenosas, Pruebas Psicológicas, Hormonas tiroideas, Hormona liberadora de tirotropina. Resumen: Thyrotropin-releasing hormone (TRH) is a tripeptide that produces endocrine and behavioral effects in animals and humans. Some studies have shown transient antidepressant activity after morning administration of TRH. Link: ./index.php?lvl=notice_display&id=30897

Rapid dose escalation with quetiapine a pilot study / Mark A. Smith en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 331-335 Título : Rapid dose escalation with quetiapine a pilot study Tipo de documento: texto impreso Autores: Mark A. Smith, Autor ; Robin McCoy, Autor ; Jennifer Hamer Maansson, Autor Fecha de publicación: 2023 Artículo en la página: pp. 331-335 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Dibenzotiacepinas, Fumarato de quetiapina, Esquizofrenia. Resumen: The original dosing recommendations for quetiapine in the treatment of schizophrenia suggested escalation to 400 mg/d using the following schedule, administered twice daily in divided doses: Day 1, 50 mg; Day 2, 100 mg; Day 3, 200 mg; Day 4, 300 mg; Day 5, 400 mg. In practice, however, clinicians often exceed these recommendations because of the need to obtain a therapeutic response in patients with psychosis as quickly as possible. Link: ./index.php?lvl=notice_display&id=30898 [artículo] Rapid dose escalation with quetiapine a pilot study [texto impreso] / Mark A. Smith, Autor ; Robin McCoy, Autor ; Jennifer Hamer Maansson, Autor . - 2023 . - pp. 331-335. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 331-335 Palabras clave: Antipsicóticos, Dibenzotiacepinas, Fumarato de quetiapina, Esquizofrenia. Resumen: The original dosing recommendations for quetiapine in the treatment of schizophrenia suggested escalation to 400 mg/d using the following schedule, administered twice daily in divided doses: Day 1, 50 mg; Day 2, 100 mg; Day 3, 200 mg; Day 4, 300 mg; Day 5, 400 mg. In practice, however, clinicians often exceed these recommendations because of the need to obtain a therapeutic response in patients with psychosis as quickly as possible. Link: ./index.php?lvl=notice_display&id=30898

Empirical testing of two models for staging antidepressant treatment resistance / Timothy Petersen en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 336-341 Título : Empirical testing of two models for staging antidepressant treatment resistance Tipo de documento: texto impreso Autores: Timothy Petersen, Autor ; George I. Papakostas, Autor ; Michael A. Posternak, Autor Fecha de publicación: 2023 Artículo en la página: pp. 336-341 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno depresivo mayor, Índice de gravedad de la enfermedad Resumen: An increasing amount of attention has been paid to treatment resistant depression. Although it is quite common to observe nonremission to not just one but consecutive antidepressant treatments during a major depressive episode, a relationship between the likelihood of achieving remission and one's degree of resistance is not clearly known at this time. Link: ./index.php?lvl=notice_display&id=30899 [artículo] Empirical testing of two models for staging antidepressant treatment resistance [texto impreso] / Timothy Petersen, Autor ; George I. Papakostas, Autor ; Michael A. Posternak, Autor . - 2023 . - pp. 336-341. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 336-341 Palabras clave: Antidepresivos, Trastorno depresivo mayor, Índice de gravedad de la enfermedad Resumen: An increasing amount of attention has been paid to treatment resistant depression. Although it is quite common to observe nonremission to not just one but consecutive antidepressant treatments during a major depressive episode, a relationship between the likelihood of achieving remission and one's degree of resistance is not clearly known at this time. Link: ./index.php?lvl=notice_display&id=30899

Drug interactions between lamotrigine and psychoactive drugs Evidence from a therapeutic drug monitoring service / Arne Reimers en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 342-348 Título : Drug interactions between lamotrigine and psychoactive drugs Evidence from a therapeutic drug monitoring service Tipo de documento: texto impreso Autores: Arne Reimers, Autor ; Eirik Skogvoll, Autor ; Janne Kutschera Sund, Autor Fecha de publicación: 2023 Artículo en la página: pp. 342-348 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Anticonvulsivos, Trastornos mentales, Enfermedades del sistema nervioso, Medicamentos Psicotrópicos, Fármacos psicotrópicos, Triazinas. Resumen: We present a systematic study on the interaction potential of lamotrigine, with focus on psychoactive drugs. A review of routine serum concentration measurements of lamotrigine performed in our laboratory yielded a total of 1733 serum samples from 829 patients (530 women, 299 men) suitable for statistical analysis. Link: ./index.php?lvl=notice_display&id=30900 [artículo] Drug interactions between lamotrigine and psychoactive drugs Evidence from a therapeutic drug monitoring service [texto impreso] / Arne Reimers, Autor ; Eirik Skogvoll, Autor ; Janne Kutschera Sund, Autor . - 2023 . - pp. 342-348. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 342-348 Palabras clave: Anticonvulsivos, Trastornos mentales, Enfermedades del sistema nervioso, Medicamentos Psicotrópicos, Fármacos psicotrópicos, Triazinas. Resumen: We present a systematic study on the interaction potential of lamotrigine, with focus on psychoactive drugs. A review of routine serum concentration measurements of lamotrigine performed in our laboratory yielded a total of 1733 serum samples from 829 patients (530 women, 299 men) suitable for statistical analysis. Link: ./index.php?lvl=notice_display&id=30900

Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence / Raymond F. Anton en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 349-357 Título : Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence Tipo de documento: texto impreso Autores: Raymond F. Anton, Autor ; Darlene H. Moak, Autor ; Patricia Latham, Autor Fecha de publicación: 2023 Artículo en la página: pp. 349-357 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Terapia de conducta cognitiva, Terapia de modalidad combinada, Motivación, Naltrexona, Antagonistas narcóticos, Índice de gravedad de la enfermedad Resumen: Although naltrexone has been shown to be effective in the treatment of alcohol dependence, less is known about its efficacy when combined with different behavioral therapies. Previous work has suggested that naltrexone works best when combined with weekly cognitive behavioral therapy (CBT). Link: ./index.php?lvl=notice_display&id=30901 [artículo] Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence [texto impreso] / Raymond F. Anton, Autor ; Darlene H. Moak, Autor ; Patricia Latham, Autor . - 2023 . - pp. 349-357. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 349-357 Palabras clave: Alcoholismo, Terapia de conducta cognitiva, Terapia de modalidad combinada, Motivación, Naltrexona, Antagonistas narcóticos, Índice de gravedad de la enfermedad Resumen: Although naltrexone has been shown to be effective in the treatment of alcohol dependence, less is known about its efficacy when combined with different behavioral therapies. Previous work has suggested that naltrexone works best when combined with weekly cognitive behavioral therapy (CBT). Link: ./index.php?lvl=notice_display&id=30901